Clinical Trial: A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Male Subjects
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-label, Fixed-sequence Study to Assess the Effects of Strong CYP1A2 Inhibitor (Fluvoxamine) on Savolitinib Exposure in Healthy Male Subjects
Brief Summary:
This study will assess the effects of strong CYP1A2 (Cytochrome P450 1A2) inhibitor (fluvoxamine) on savolitinib exposure in healthy male subjects, performed at a single clinical unit.
Read more